Induction of regulator of G-protein signaling 2 expression by long-acting β2-adrenoceptor agonists and glucocorticoids in human airway epithelial cellss

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 1, 2014, Pages 12-24

  Holden, Neil S ^a   George, Tresa ^a   Rider, Christopher F ^a   Chandrasekhar, Ambika ^a   Shah, Suharsh ^a   Kaur, Manminder ^b   Johnson, Malcolm ^b   Siderovski, David P ^b   Leigh, Richard ^b   Giembycz, Mark A ^b   Newton, Robert ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b GLAXOSMITHKLINE   (United Kingdom)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BUDESONIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXAMETHASONE; FLUTICASONE PROPIONATE; FORMOTEROL; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTERLEUKIN 8; MESSENGER RNA; RGS2 PROTEIN; SALMETEROL;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RGS2 GENE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; DRUG COMBINATIONS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; RESPIRATORY MUCOSA; RGS PROTEINS; TIME FACTORS;

EID: 84890447102     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.204586     Document Type: Article

References (63)

1. Ayroldi E and Riccardi C (2009) Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23:3649-3658.
2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, and Pedersen SE, et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143-178.
3. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, and Vestbo J; TORCH investigators (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775-789.
4. Chang TS, Kim MJ, Ryoo K, Park J, Eom SJ, Shim J, Nakayama KI, Nakayama K, Tomita M, and Takahashi K, et al. (2003) p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem 278:48092-48098.
5. Chivers JE, Gong W, King EM, Seybold J, Mak JC, Donnelly LE, Holden NS, and Newton R (2006) Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol Pharmacol 70:2084-2095.
6. Clark AR, Martins JR, and Tchen CR (2008) Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem 283:25765-25769.
7. Dent G, White SR, Tenor H, Bodtke K, Schudt C, Leff AR, Magnussen H, and Rabe KF (1998) Cyclic nucleotide phosphodiesterase in human bronchial epithelial cells: characterization of isoenzymes and functional effects of PDE inhibitors. Pulm Pharmacol Ther 11:47-56.
8. Diefenbacher M, Sekula S, Heilbock C, Maier JV, Litfin M, van Dam H, Castellazzi M, Herrlich P, and Kassel O (2008) Restriction to Fos family members of Trip6- dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol Endocrinol 22:1767-1780.
9. Edwards MR, Johnson MW, and Johnston SL (2006) Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 34:616-624.
10. Esmailpour N, Högger P, Rabe KF, Heitmann U, Nakashima M, and Rohdewald P (1997) Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 10:1496-1499.
11. FuhrmannM, Jahn HU, Seybold J, Neurohr C, Barnes PJ, Hippenstiel S, Kraemer HJ, and Suttorp N (1999) Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol 20:292-302.
12. Gelfand EW (2002) Role of histamine in the pathophysiology of asthma: immunomodulatory and anti-inflammatory activities of H1-receptor antagonists. Am J Med 113 (Suppl 9A):2S-7S.
13. Giembycz MA, Kaur M, Leigh R, and Newton R (2008) A holy grail of asthma management: toward understanding how long-acting b2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 153: 1090-1104.
14. Giembycz MA and Newton R (2006) Beyond the dogma: novel b2-adrenoceptor signalling in the airways. Eur Respir J 27:1286-1306.
15. Gosens R, Zaagsma J, Meurs H, and Halayko AJ (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7:73.
16. Greer S, Page CW, Joshi T, Yan D, Newton R, and Giembycz MA (2013) Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease. J Pharmacol Exp Ther 346: 473-485.
17. Gwilt CR, Donnelly LE, and Rogers DF (2007) The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 115:208-222.
18. Henderson WR, Jr, Chiang GK, Tien YT, and Chi EY (2006) Reversal of allergeninduced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 173:718-728.
19. Henderson WR, Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, and Chi EY (2002) A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 165:108-116.
20. Heximer SP (2004) RGS2-mediated regulation of Gqa. Methods Enzymol 390: 65-82.
21. Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, Azuma T, Yamaoka Y, Sap J, and Yamasaki E, et al. (2008) Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kB activation. J Immunol 180: 5017-5027.
22. Holden NS, Bell MJ, Rider CF, King EM, Gaunt DD, Leigh R, Johnson M, Siderovski DP, Heximer SP, and Giembycz MA, et al. (2011) b2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proc Natl Acad Sci USA 108:19713-19718.
23. Holden NS, Gong W, King EM, Kaur M, Giembycz MA, and Newton R (2007) Potentiation of NF-kB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells. Br J Pharmacol 152:891-902.
24. Holgate ST, Peters-Golden M, Panettieri RA, and Henderson WR, Jr. (2003) Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111(1, Suppl)S18-S34, discussion S34-S36.
25. Huszár E, Szabó Z, Jakab A, Barta I, Herjavecz I, and Horváth I (2005) Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays. Inflamm Res 54:350-355.
26. Johnson M (2000) Mechanisms of action of b2-adrenoceptor agonists, in Asthma & Rhinitis (Busse WW and Holgate ST, eds) pp 1541-1568, Blackwell Science, Oxford.
27. Jones RL, Giembycz MA, and Woodward DF (2009) Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol 158: 104-145.
28. Kaur M, Chivers JE, Giembycz MA, and Newton R (2008) Long-acting b2- adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73:203-214.
29. Kelly MM, King EM, Rider CF, Gwozd C, Holden NS, Eddleston J, Zuraw B, Leigh R, O'Byrne PM, and Newton R (2012) Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol 165:1737-1747.
30. Kimple AJ, Soundararajan M, Hutsell SQ, Roos AK, Urban DJ, Setola V, Temple BR, Roth BL, Knapp S, and Willard FS, et al. (2009) Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2). J Biol Chem 284:19402-19411.
31. King EM, Holden NS, Gong W, Rider CF, and Newton R (2009) Inhibition of NF-kBdependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 284:26803-26815.
32. King EM, Chivers JE, Rider CF, Minnich A, Giembycz MA, and Newton R (2013) Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms. PLoS ONE 8:e53936.
33. Knight DA and Holgate ST (2003) The airway epithelium: structural and functional properties in health and disease. Respirology 8:432-446.
34. Koyama S, Rennard SI, and Robbins RA (1992) Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 262:L466-L471.
35. Koyama S, Sato E, Nomura H, Kubo K, Nagai S, and Izumi T (1998) Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol (1985) 84:1528-1534.
36. Kyriakis JM and Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
37. Manetsch M, Ramsay EE, King EM, Seidel P, Che W, Ge Q, Hibbs DE, Newton R, and Ammit AJ (2012) Corticosteroids and b2-agonists upregulate mitogenactivated protein kinase phosphatase 1: in vitro mechanisms. Br J Pharmacol 166:2049-2059.
38. Matsubara M, Ohmori K, and Hasegawa K (2006) Histamine H1 receptor-stimulated interleukin 8 and granulocyte macrophage colony-stimulating factor production by bronchial epithelial cells requires extracellular signal-regulated kinase signaling via protein kinase C. Int Arch Allergy Immunol 139:279-293.
39. Meja KK, Catley MC, Cambridge LM, Barnes PJ, Lum H, Newton R, and Giembycz MA (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the antiinflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther 309:833-844.
40. Miller-Larsson A and Selroos O (2002) No evidence of glucocorticosteroid- induced apoptosis of airway epithelial cells in vivo. Am J Respir Crit Care Med 165: 1567-1568, author reply 1567-1568.
41. Moodley T, Wilson SM, Joshi T, Rider CF, Sharma P, Yan D, Newton R, and Giembycz MA (2013) Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease. Mol Pharmacol 83:894-906.
42. Müller T, Myrtek D, Bayer H, Sorichter S, Schneider K, Zissel G, Norgauer J, and Idzko M (2006) Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med 18:925-931.
43. Newton R (2013) Anti-inflammatory glucocorticoids: changing concepts. Eur J Pharmacol DOI: 10.1016/j.ejphar.2013.05.035 [published ahead of print].
44. Newton R and Holden NS (2007) Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72: 799-809.
45. Newton R, Holden NS, Catley MC, Oyelusi W, Leigh R, Proud D, and Barnes PJ (2007) Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkB kinase inhibitors. J Pharmacol Exp Ther 321: 734-742.
46. Newton R, King EM, Gong W, Rider CF, Staples KJ, Holden NS, and Bergmann MW (2010a) Glucocorticoids inhibit IL-1b-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Biochem J 427: 113-124.
47. Newton R, Leigh R, and Giembycz MA (2010b) Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases. Pharmacol Ther 125:286-327.
48. Pang L and Knox AJ (2000) Synergistic inhibition by b2-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23:79-85.
49. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, and Ullman A; Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337:1405-1411.
50. Penn RB and Benovic JL (2008) Regulation of heterotrimeric G protein signaling in airway smooth muscle. Proc Am Thorac Soc 5:47-57.
51. Profita M, Bonanno A, Siena L, Ferraro M, Montalbano AM, Pompeo F, Riccobono L, Pieper MP, and Gjomarkaj M (2008) Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur J Pharmacol 582:145-153.
52. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, and van Weel C, et al.; Global Initiative for Chronic Obstructive Lung Disease (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555.
53. Rider CF, King EM, Holden NS, Giembycz MA, and Newton R (2011) Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting b2-adrenoceptor agonists. J Pharmacol Exp Ther 338:860-869.
54. Roy AA, Nunn C, Ming H, Zou MX, Penninger J, Kirshenbaum LA, Dixon SJ, and Chidiac P (2006) Up-regulation of endogenous RGS2 mediates crossdesensitization between Gs and Gq signaling in osteoblasts. J Biol Chem 281: 32684-32693.
55. Sales ME (2010) Muscarinic receptors as targets for anti-inflammatory therapy. Curr Opin Investig Drugs 11:1239-1245.
56. Shrewsbury S, Pyke S, and Britton M (2000) Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 320:1368-1373.
57. Suzuki Y, Asano K, Niimi K, Miyata J, Shiraishi Y, Fukunaga K, Shiomi T, Nakajima T, Oguma T, and Sayama K, et al. (2008) TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells. Eur J Pharmacol 600:133-139.
58. Takizawa H, Ohtoshi T, Kikutani T, Okazaki H, Akiyama N, Sato M, Shoji S, and Ito K (1995) Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro. Int Arch Allergy Immunol 108:260-267.
59. Todorova L, Gürcan E, Miller-Larsson A, and Westergren-Thorsson G (2006) Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. Am J Respir Cell Mol Biol 34:92-100.
60. Tsingotjidou A, Nervina JM, Pham L, Bezouglaia O, and Tetradis S (2002) Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 39,59- monophosphate-mediated pathway in primary neonatal murine osteoblasts. Bone 30:677-684.
61. van den Brink KI, Boorsma M, Staal-van den Brekel AJ, Edsbäcker S, Wouters EF, and Thorsson L (2008) Evidence of the in vivo esterification of budesonide in human airways. Br J Clin Pharmacol 66:27-35.
62. Xie Y, Jiang H, Nguyen H, Jia S, Berro A, Panettieri RA, Jr, Wolff DW, Abel PW, Casale TB, and Tu Y (2012) Regulator of G protein signaling 2 is a key modulator of airway hyperresponsiveness. J Allergy Clin Immunol 130:968-976, e3.
63. Yamamoto T, Digumarthi H, Aranbayeva Z, Wataha J, Lewis J, Messer R, Qin H, Dickinson D, Osaki T, and Schuster GS, et al. (2007) EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase. Toxicol Appl Pharmacol 224:318-325.